Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
US5194448A · kind A · utility
29Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 1991 |
| Grant date | Mar 16, 1993 |
| Priority date | — |
| Expiry date | Aug 6, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Composition containing nervonic acid (cis-tetracos-15-enoic acid) in a physiologically acceptable form are useful in the treatment of demyelinating disease, such as multiple sclerosis. Additional long chain fatty acids of chain length C16 to C26, especially erucic acid, or their esters, may be included in such compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.